Predictors of the Efficacy of FOLFIRI plus Bevacizumab as Second-Line Treatment in Metastatic Colorectal Cancer Patients
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-08-01
著者
-
Hatake Kiyohiko
Department Of Medical Oncology Cancer Institute Hospital Of Japanese Foundation For Cancer Research
-
Shinozaki Eiji
Department Of Medical Oncology Cancer Institute Hospital Of Japanese Foundation For Cancer Research
-
Hatake Kiyohiko
Division Of Medical Oncology Cancer Institute Hospital
-
Hatake Kiyohiko
Department Of Hematology Jichi Medical School
-
MATSUSAKA Satoshi
Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research
-
Yamaguchi Toshiharu
Department Of Gastroenterological Surgery Cancer Institute Hospital
-
Hirata Kouichi
First Department Of Surgery Sapporo Medical College
-
Ueno Masashi
Division Of Gastroenterological Surgery Cancer Institute Hospital
-
Mizunuma Nobuyuki
Department Of Medical Oncology Cancer Institute Hospital Of Japanese Foundation For Cancer Research
-
Mizunuma Nobuyuki
Department Of Medical Oncology Cancer Institute Hospital
-
Hatake Kiyohiko
Olympus Bio-imaging Laboratory The Cancer Chemotherapy Center Of The Jfcr
-
Hatake Kiyohiko
Department Of Medical Oncology Ariake Cancer Institute Hospital
-
Ueno Masashi
Department Of Condensed Matter Physics Tokyo Institute Of Technology
-
Matsusaka Satoshi
Department Of Medical Oncology Cancer Institute Hospital Of Japanese Foundation For Cancer Research
-
Matsusaka Satoshi
Department Of Hygiene And Preventive Medicine Yamagata University School Of Medicine
-
Suenaga Mitsukuni
Department Of Medical Oncology Cancer Institute Hospital Of Japanese Foundation For Cancer Research
-
Yamamoto Noriko
Department Of Biology Faculty Of Science And Engineering Konan University
-
Yamamoto Noriko
Department Of Pathology Cancer Institute Hospital Of Japanese Foundation For Cancer Research
-
Yamamoto Noriko
Department Of Applied Chemistry Faculty Of Science And Technology Keio University
-
Yamaguchi Toshiharu
Gastroenterological Center Department Of Gastroenterological Surgery
-
Yamaguchi Toshiharu
Department Of Experimental Pathology And Tumor Biology Graduate School Of Medical Sciences Nagoya Ci
-
Yamaguchi Toshiharu
Department Of Gastroenterological Surgery Gastroenterological Center Cancer Institute Hospital Japanese Foundation For Cancer Research
-
Mizunuma Nobuyuki
Department Of Medical Oncology Ariake Cancer Institute Hospital
関連論文
- OJ-289 CD34 Positive Cells in the Coronary Circulation Increase with Cytokines Induced by Ischemic Condition(Acute coronary syndrome, basic/clinical-3 (IHD) OJ49,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese C
- OJ-289 CD34 Positive Cells in the Coronary Circulation Increase with Cytokines Induced by Ischemic Condition(Acute coronary syndrome, basic/clinical-3 (IHD) OJ49,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese C
- No beneficial effect from addition of etoposide to daunorubicin,cytarabine,and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia:the JALSG-AML92 study
- Successful Treatment of Multiple Myeloma-Associated Amyloidosis by Interferon-α, Dimethyl Sulfoxide, and VAD(Vincristine, Adriamycin, and Dexamethasone)
- Phenotypic Conversion of T-Lineage Lymphoblasts in the Lymph Node to Myeloblasts in the Bone Marrow During Relapse After Allogeneic Bone Marrow Transplantation
- Increased incidence of interstitial pneumonia by CHOP combined with rituximab
- A Case of Acute Promyelocytic Leukemia during Gefitinib Treatment
- Efficacy of S-1 in heavily pretreated patients with metastatic breast cancer : cross-resistance to capecitabine
- Pilot study of MDR1 gene transfer into hematopoietic stem cells and chemoprotection in metastatic breast cancer patients
- Does Lapatinib, a Small-Molecule Tyrosine Kinase Inhibitor, Constitute a Breakthrough in the Treatment of Breast Cancer?